(3ASR,4RS,8ASR,8BRS)-4-(2-(4-fluorobenzyl)-1,3-dioxodecahydropyrrolo[3,4-a]pyrrolizin-4-yl)benzamidine

This compound is an experimental small molecule belonging to the phenylpyrrolidine class of organic compounds. It features a polycyclic structure with both fluorinated and benzamidine moieties. The molecule has been studied as a ligand in structural biology and chemical biology research but is not approved for clinical use or any therapeutic indication. Its mechanism of action and biological targets are not well characterized in the public domain. There are no known approved indications or ongoing clinical trials for this compound as of now[1][2][10].

Other names

(3ASR,4RS,8ASR,8BRS)-4-(2-(4-fluorobenzyl)-1,3-dioxodecahydropyrrolo[3,4-a]pyrrolizin-4-yl)benzamidineAmino{4-[(3aS,4R,8aS,8bR)-2-(4-fluorobenzyl)-1,3-dioxodecahydropyrrolo[3,4-a]pyrrolizin-4-yl]phenyl}methaniminium({4-[(3aS,4R,8aS,8bR)-2-[ ( ̶ ̶f̶l̶u̶o̶r̶o̶p̶h e n y l ) m e t h y l ] - 1 , 3 - d i o x o - d e c a h y d r o p y r r o l o [ 3 , 44 a ] p y r r o l i z i n - 44 - y l ] p h e n y l }( a m i n o ) m e t h yl idene)azanium